- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-3111
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Renin–Angiotensin–Aldosterone Inhibitors and COVID-19 Infection ; day:18 ; month:6 ; year:2022 ; pages:1-9
Current hypertension reports ; (18.6.2022), 1-9
- Urheber
-
Tsampasian, Vasiliki
Corballis, Natasha
Vassiliou, Vassilios S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11906-022-01207-3
- URN
-
urn:nbn:de:101:1-2022081220042022921517
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tsampasian, Vasiliki
- Corballis, Natasha
- Vassiliou, Vassilios S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors
Impact of hyperkalaemia on renin–angiotensin–aldosterone (RAAS) inhibitor reduction or withdrawal following hospitalisation
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension
Role of Renin-Angiotensin-Aldosterone System (RAAS) inhibition in the renal continuum
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors
Impact of hyperkalaemia on renin–angiotensin–aldosterone (RAAS) inhibitor reduction or withdrawal following hospitalisation
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension
Role of Renin-Angiotensin-Aldosterone System (RAAS) inhibition in the renal continuum
The renin angiotensin aldosterone system
Symposium Renin-Angiotensin-Aldosterone System and Hypertension
Recommendations for the management of hyperkalemia in patients receiving renin–angiotensin–aldosterone system inhibitors
Impact of hyperkalaemia on renin–angiotensin–aldosterone (RAAS) inhibitor reduction or withdrawal following hospitalisation
Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19
Independent regulation of renin–angiotensin–aldosterone system in the kidney
Renin angiotensin aldosterone system blockade in practice: A Clinical Perspective
Local Angiotensin-Converting Enzyme 2 Gene Expression in Kidney Allografts Is Not Affected by Renin-Angiotensin-Aldosterone Inhibitors
Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors Secondary to Hyperkalemia Translates into Higher Cardiorenal Outcomes
The renin–angiotensin–aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II
Cross-talk between exercises and renin-angiotensin-aldosterone-system blockade in hypertension